IRulya Therapeutics QNCX
NASDAQ QNCX
$40.27 +5.82 (+16.89%)
At close: Oct 20, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Total Debt (2023 - 2025)

Updated

IRulya Therapeutics (QNCX) recorded Total Debt of $18.03 million in Q4 2025, up 2.9% from the prior quarter.

Analysis

Quince Therapeutics, Inc. (QNCX) Total Debt (2023 - 2025) Analysis & Trends

Starting with Q4 2023, IRulya Therapeutics' Total Debt history includes 8 quarters.

  • Across earlier years, Total Debt came in at $13.43 million in FY2023.
  • The Q4 2025 figure is the highest quarterly Total Debt in data going back to Q4 2023.
  • Per Business Quant, the preceding three quarters came in at $17.52 million (Q3 2025), $16.99 million (Q2 2025) and $15.27 million (Q1 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 18.03 Mn
Sep 30, 2025 17.52 Mn
Jun 30, 2025 16.99 Mn
Mar 31, 2025 15.27 Mn
Sep 30, 2024 14.90 Mn
Jun 30, 2024 13.83 Mn
Mar 31, 2024 13.52 Mn
Dec 31, 2023 13.43 Mn
API Access

Quince Therapeutics, Inc. Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=QNCX&period=max&api_key=YOUR_API_KEY